Celebrity Inventors
Actress Jamie Lee Curtis is a patented inventor - she created a diaper equipped with a premoistened baby wipe. And that's no act!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7282575 | Functional peptide nucleic acid monomer and process for producing the same A compound represented by the general formula (I) below: In the formula, A is as defined in the specification and B denotes where n is an integer of 1 to 4, ... | 10/16/2007 |
| 7235674 | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof The present invention is directed to substituted coumarins and quinolines and analogs thereof, represented by the general Formula I: wherein A, B, X, Y, and Z are defined herein. The present invention also relate... | 06/26/2007 |
| 7150967 | Fluorescent tags for amino acid and nucleic acid analysis Methods and kits for labeling and detecting thiol containing species and nucleic acids using mercurimethyl-dihydropsoralen compounds and derivatives thereof which intercalate nucleic acids and are highly reactive with thiol containing species are provided. Fluoresce... | 12/19/2006 |
| 7074933 | Urea and thiourea derivatives The invention is directed to a new class of quinolin-zene and z-exc chromen compounds that have been derivatized at the 6-position with a urea or this urea moet, and to then use as androgen antagonists. ... | 07/11/2006 |
| 6864254 | Inhibitor for 20-hete-yielding enzyme An inhibitor for 20-hydroxyeicosatetraenoic acid production which comprises as the active ingredient a specific hydroxyformamidine derivative or a pharmacologically acceptable salt thereof. It is useful especially as a remedy for kidney diseases, cerebrovascular dis... | 03/08/2005 |
| 6770385 | Fluorescent bis-coumarins for organic light-emitting devices A fluorescent compound, suitable for use in an active layer of an organic light-emitting device and exhibiting both good luminescence and excellent thermal stability, which has the structure wherein R is substituted or u... | 08/03/2004 |
| 6747060 | Non-natural galanin receptor ligands Compounds which are non-natural galanin receptor ligands are disclosed. The ligands are of small size, have agonist or antagonist galanin activity and may cross the blood-brain barrier to displace galanin from galanin receptors. The ligands are useful as medicaments... | 06/08/2004 |
| 6680178 | Profiling of protease specificity using combinatorial fluorogenic substrate libraries A method is presented for the preparation and use of fluorogenic peptide substrates that allows for the configuration of general substrate libraries to rapidly identify the primary and extended specificity of enzymes, such as proteases. The substrates con... | 01/20/2004 |
| 6673557 | Methods of treatment of eye trauma and disorders Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatmen... | 01/06/2004 |
| 6627111 | Organic light emitting displays and new fluorescent compounds An organic light emitting display is provided which comprises as an emitting layer a fluorescent dye having at least one amine moiety substituted with two aryl groups. Also provided are new fluorescent compounds having N-aryl substituents which exhibit re... | 09/30/2003 |
| 6500846 | CDK inhibitors having flavone structure The present invention relates to a novel flavone derivative, pharmaceutically acceptable salt, hydrate, solvate and isomer thereof which is useful as an inhibitor against Cyclin Dependent Kinase (CDK), a process for preparation thereof, and a composition ... | 12/31/2002 |
| 6455579 | Pyran derivatives Disclosed are pyran derivatives, which have distinctive sensitivity to visible light and distinctive luminous ability. The derivatives are useful in photopolymerization, electroluminescence, and dye lasers, and are obtainable through a step of reacting a ... | 09/24/2002 |
| 6358696 | Methods of treatment of eye trauma and disorders Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatmen... | 03/19/2002 |
| 6344334 | Pharmacophore recombination for the identification of small molecule drug lead compounds Method for identifying a drug lead compound that inhibits binding of target bioogical molecules (TBM) by contacting TBM with members of a library of candidate cross-linked target binding fragments (CXBF), each CXBF having at least two candidate target bin... | 02/05/2002 |
| 6344330 | Pharmacophore recombination for the identification of small molecule drug lead compounds The present invention is directed to novel methods for identifying small molecule ligands that are capable of binding with high affinity to a biological target molecule of interest. High affinity binding ligands identified by the described methods find us... | 02/05/2002 |
| 6251948 | Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induce... | 06/26/2001 |
| 6242198 | Methods of treatment of eye trauma and disorders Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatmen... | 06/05/2001 |
| 6037365 | Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation This invention provides a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutical compositions of such compounds and a method of treatment to inhibit aggregation of platelets.... | 03/14/2000 |
| 6034121 | Chromone fungicides Compounds of the formula ##STR1## where one of Z and Y is CO and the other is C--W--R2 and the dotted line indicates a double bond is present where necessary to meet valency requirements, W is O, S(O)n, N(R3), N(R | 03/07/2000 |
| 6025387 | Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease The present invention relates to novel flavone/flavanone compounds or their pharmaceutically acceptable salts and process for preparation thereof for protecting gastrointestinal tracts against gastritis, ulcers and inflammatory bowel disease.... | 02/15/2000 |
| 6002020 | Process for the catalytic preparation of 3-isochromanones from phthalans Good yields and selectivities are achieved in a process for preparing an isochroman-3-one of the formula (I) ##STR1## by reacting a 1,3-dihydroisobenzofuran of the formula (II) ##STR2## with carbon monoxide at a CO pressure of from 0.1 to 20 MPa... | 12/14/1999 |
| 5939563 | O-methyloximes of benzopyran-3,4- and benzofuran-2,3-diones and methods for their preparation Compounds of formula (XXIII): ##STR1## wherein p is 0 or 1, and processes for making such compounds.... | 08/17/1999 |
| 5840922 | Coumarin derivatives, and processes for their preparation The present invention relates to new coumarin derivatives represented by the general formula I ##STR1## wherein R1 =NH2 or --NHCH.dbd.C(CO2 C2 H5)2, R2 =R3 =R | 11/24/1998 |
| 5798390 | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induce... | 08/25/1998 |
| 5777162 | Intermediates for the preparation of fungicides Described herein are compounds of Formula (XX) and Formula (XXIV), shown below, and processes of making same. ##STR1## wherein p is 0 ##STR2## wherein p is 1, and Y is chlorine or bromine.... | 07/07/1998 |
| 5767162 | Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induce... | 06/16/1998 |
| 5703113 | Benzopyran derivatives The invention relates to benzopyran compounds of formula (I) possessing pharmacological activity, as well as to pharmaceutical compositions containing the compounds of formula (I) and processes for the preparation thereof. ##STR1##... | 12/30/1997 |
| 5696157 | Sulfonated derivatives of 7-aminocoumarin The present invention describes 7-aminocoumarin dyes that are substituted one or more times at the 3-, 6- and/or 8-positions by a sulfonic acid or a salt of a sulfonic acid, said dyes being useful as fluorescent probes or in the preparation of enzyme subs... | 12/09/1997 |
| 5652260 | Adenosine diphosphoribose polymerase binding nitroso aromatic compound useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents The subject invention provides for novel compounds for inactivating viruses. These compounds include 6-nitroso-1,2-benzopyrone, 3-nitrosobenzamide, 5-nitroso-1(2H)-isoquinolinone, 7-nitroso-1(2H)-isoquinolinone, 8-nitroso-1(2H)-isoquinolinone. The in... | 07/29/1997 |
| 5559154 | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induce... | 09/24/1996 |
| 5484951 | 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents Unsubstituted or substituted 5-iodo-6-amino-1,2-benopyrones and their metabolites are potent, selective and non-toxic inhibitors and suppressants of cancer growth and viral infections in a mammalian host. The compounds are particularly useful for treatmen... | 01/16/1996 |
| 5342970 | Hydrosoluble coumarin derivatives, their preparation and their use as an enzyme substrate or for the preparation of such substrates The invention relates to hydrosoluble coumarin derivatives. These derivatives comply with the formula: ##STR1## in which R1 represents ##STR2## with m=1 to 30 and in which R7 can be a hydrogen atom or various groups, R... | 08/30/1994 |
| 5336689 | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induce... | 08/09/1994 |
| 5300656 | Coumarin derivatives, process for their preparation, their use and thiazolyl acetic acid derivatives as intermediates Coumarin deviatives of the formula ##STR1## in which R1 denotes cyano, R2 represents phenyl or thiazolyl bonded in the 2-, 4-, or 5-position, R3 denotes hydrogen, C1 -C4 -alkyl or C1 -C4 | 04/05/1994 |
| 5300646 | Heterocyclic amine derivatives, their production and use A novel heterocyclic amine derivative of the general formula: ##STR1## wherein a ring A and a ring B stand independently for an optionally substituted benzene ring, Zo stands for O or S or ##STR2## stands for --CH2 --, X st... | 04/05/1994 |
| 5298657 | Preparation of substituted guanidines A process for the preparation of a substituted guanidine by reacting a substituted cyanamide with ammonia or a substituted amine in the presence of a Lewis acid catalyst. Also disclosed is a process for the preparation of a tri-substituted guanidine by re... | 03/29/1994 |
| 5262568 | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induce... | 11/16/1993 |
| 5262545 | Fluorescent chloramphenicol derivatives for determination of chloramphenicol acetyltransferase activity Fluorescent compounds useful in the determination of chloramphenicol acetyltransferase (CAT) enzyme activity are described. The compounds are fluorescent derivatives related in structure to chloramphenicol comprising a base, ##STR1## substituted... | 11/16/1993 |
| 5198462 | Heterocyclic amine, derivatives, their production and use A novel heterocyclic amine derivative of the general formula: ##STR1## wherein a ring A and a ring B stand independently for an optionally substituted benzene ring, Z° stands for O or S or ##STR2## stands for --CH2 --, X stands for O... | 03/30/1993 |
| 5136036 | Synthesis of mannojirimycin derivatives -Homojirimycin and 6-dpi-homojirimycin are each synthesized from 2-azido-2-deoxy-3,4:6,7-di-O- isopropylidene-D-glydero-D-talo-heptono-1,5-lactone in which the side chain acetonide is hydrolyzed to give the corresponding diol which is then pro... | 08/04/1992 |
